Invitae Corporation (NVTA)

This is NVTA and PACB:
Question:
Simon - what do u think of the NGS company Jason has gone to ? Would it’s acquisition by $NVTA make $NVTA fully vertically integrated, like $TSLA? Is that the missing link for a run away winner in the Diagnostics/monitoring space ?

Simon answers:
I don't follow GenapSys too closely, but I imagine they could eat away at the low-throughput end of NGS if everything goes to plan. I'm not certain Illumina focuses too heavily on that part of its portfolio. Invitae already is fairly vertically integrated, however ...
... as far as hardware is concerned, prenatal screening is migrating to Singular Bio instruments, a company Invitae bought in 2019. For the main sequencing cluster, I would guess that most of it moves to HiFi sequencing in the coming years. While that certainly isn't full ...
.. vertical integration, Invitae will receive preferential economics for ~5 years given the nature of its agreement with PacBio.

I like Invitae because it seems to be the market-leader in making genetic-diagnostic testing the standard of care, especially cost wise. I see only opportunity for more bespoke testing, upsell solutions to existing customer base, and a huge total addressable market, plus first-mover advantage with providers.

What I’m failing to understand is why $NVTA is consistently compared to $BNGO. The latter seems less consumer-facing, more B2B and more hardware focused with visualization software. Am I correct in that NVTA is more likely to be a client of BNGO than the other way around?

NVTA’s model appears to be a lot more scalable. They seem less competitors and more complimentary pieces within the same puzzle.

For those in the medical field, what exactly makes BNGO’s technology superior? My layperson view is that NVTA does gene-sequencing at a high-level for efficiency, while BNGO does gene-mapping at a MUCH closer and granular view - albeit higher cost? BNGO claims to be better than Next-Gen sequencing but the key question is whether their product is more than the market requires, whereas NVTA is a mass-solution, more accessible to people and providers.

I’m currently long $NVTA and have yet to buy $BNGO. Curious if anyone owns both, and if so, what your distinction is between the two. Thanks!

Markets going up 5% tomorrow:

CANCEL ALL SELL ORDERS FOR TOMORROW MORNING

#BRK-B #AMD #RVLV #VGLT #VWO #ARKK #AMZN #TSLA #AAPL #CIBR #NVTA #MAIN #VYM #KR #TXRH #SPXL #

Bloomberg feed:

You think Snowflake was big? Well, let me tell you a thing or two. Bill Ackman's ego is even bigger, and with the largest SPAC in history he is going to have the most blockbuster listing. It's going to be so huge, even Buffett's chair is going to wobble when he sees this. He's got a war chest of 4 billion with additional capital he can allocate up to 7 billion. No fees. The only performance he get's is the appreciation of the stock price.

Airbnb thinks it's cute telling everyone they are going to go the IPO route, but let's be real tea, they cannot wait that long for a cash infusion and don't want to leave money on the table or risk falling below their IPO price with a valuation by the public uncertain. That was a cute trick to try fool Ackman they have other options, but they really don't. No more growth equity money is going into that.

Ackman has stated many times he wants a deal done this year and that now is the time. He already made arguably the best YOLO in history, turning 2.7m into 2.7b in about 10 days. He's on fire and is going to do it with PSTH.

I'm basically all-in.

Positions:

$PSTH 3/19/21 20c & 25c

Target Price: $40+

Note my previous YOLO: $NVTA is ITM.

Nate Anderson (author behind @HindenburgRes
short piece against $PRED) is heavily promoting $NVTA on his personal Twitter:
(link: https://twitter.com/ClarityToast) twitter.com/ClarityToast
Now we understand why he is attacking Predictive Technologies Group - to destroy competition